Virtu Financial LLC Tiziana Life Sciences LTD Transaction History

Virtu Financial LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$0.55 - $0.83 $1,639 - $2,474	2,981 Added 23.67%	15,577 $12,000
Q2 2022 Aug 09, 2022	SELL	$0.66 - $1.06 $12,368 - $19,864	-18,740 Reduced 59.8%	12,596 $9,000
Q1 2022 May 17, 2022	BUY	$0.62 - $1.25 $3,272 - $6,597	5,278 Added 20.25%	31,336 $33,000
Q4 2021 Feb 17, 2022	BUY	$0.89 - $1.66 $23,191 - $43,256	26,058 New	26,058 $25,000

1.03M

19.2K

Ticker TLSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,273,000
Market Cap $91M
Description
Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, m...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.